| Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans | Clinical Infectious Diseases | 2005 | 560 |
| Urease as a virulence factor in experimental cryptococcosis | Infection and Immunity | 2000 | 395 |
| Single-dose oritavancin in the treatment of acute bacterial skin infections | New England Journal of Medicine | 2014 | 199 |
| Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens | Clinical Infectious Diseases | 2003 | 198 |
| Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production | Eukaryotic Cell | 2006 | 184 |
| RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells | Journal of Virology | 2003 | 173 |
| Sequence-based differentiation of strains in the Mycobacterium avium complex | Journal of Bacteriology | 1993 | 160 |
| Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients | Journal of Infectious Diseases | 2002 | 155 |
| Underresourced hospital infection control and prevention programs: penny wise, pound foolish? | Infection Control and Hospital Epidemiology | 2007 | 146 |
| Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition | New England Journal of Medicine | 2021 | 77 |
| Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee | Transplantation | 2015 | 75 |
| Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae | Antimicrobial Agents and Chemotherapy | 2006 | 67 |
| Cryptococcus neoformans methionine synthase: expression analysis and requirement for virulence | Microbiology (United Kingdom) | 2004 | 63 |
| HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest | Virology | 2003 | 55 |
| Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrier | PLoS Pathogens | 2013 | 54 |
| Detection of minor drug-resistant populations by parallel allele-specific sequencing | Nature Methods | 2007 | 54 |
| Long-term sequelae of Rocky Mountain spotted fever | Clinical Infectious Diseases | 1995 | 52 |
| In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients | Antimicrobial Agents and Chemotherapy | 2004 | 51 |
| "It's like losing a part of my family": transition expectations of adolescents living with perinatally acquired HIV and their guardians | AIDS Patient Care and STDs | 2012 | 49 |
| Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial | | 2021 | 46 |
| Fungal infection prevention after hematopoietic cell transplantation | Bone Marrow Transplantation | 2009 | 43 |
| Septic arthritis due to Mycoplasma hominis | Arthritis and Rheumatism | 1983 | 35 |
| Urinary Tract Infection and Neurogenic Bladder | Urologic Clinics of North America | 2015 | 34 |
| Surgical volume and the risk of surgical site infection in community hospitals: size matters | Annals of Surgery | 2008 | 30 |
| Evolutionary bottlenecks in the agents of tuberculosis, leprosy, and paratuberculosis | Medical Hypotheses | 1999 | 29 |
